Tong Yang Life Insurance Co., Ltd. (082640.KS)
Seoul, KR
Tong Yang Life Insurance Co., Ltd. primarily functions as a life insurance provider within South Korea. The company's offerings extend to accident compensation and child insurance policies, alongside retirement planning solutions and asset management services. Its products are distributed directly to clients, through general agencies, and via its five dedicated business divisions. Established in 1989, the company maintains its headquarters in Seoul, South Korea.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -1.29% | -4.97% | -12.57% | +4.51% | +14.69% | +19.53% | +35.40% | +115.19% | +25.41% | -30.14% | -45.94% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 1 | +1 |
| Buy | 0 | 0 |
| Hold | 0 | -1 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Insurance - Life: +10.6%+44.7% ★ Q1'26: +60.6% (vs Q1'25)
-
EPS growth Insurance - Life: +13.4%-61.7% Q1'26: -47.6% (vs Q1'25)
-
FCF margin FCF growth · Insurance - Life: +31.7%-115.3% Q1'26: -464.8% (vs Q1'25)
-
EBIT margin Insurance - Life: +12.4%+4.9% Q1'26: +2.8% (vs Q1'25)
-
ROIC Insurance - Life: +1.0%+4.9% ★ Q1'26: +4.9% (vs Q1'25)
-
Share dilution Insurance - Life: +0.4%+3.5% Q1'26: +3.4% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Insurance - Life: -1.05×7.13× Q1'26: 10.08× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 1 Rev. Ana. 1 EPS Ana. |
Dec 2027 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
4.49T
est: 4.00T (+12.1%)
|
6.73T
est: 6.56T (+2.5%)
|
6.29T
est: 5.86T (+7.2%)
|
5.25T
est: 5.05T (+4.1%)
|
5.44T
est: 4.23T (+28.7%)
|
5.85T
est: 5.41T (+8.1%)
|
5.46T
est: 5.54T (-1.5%)
|
1.78T
est: 6.46T (-72.5%)
|
2.50T
est: 4.51T (-44.5%)
|
2.47T
est: 4.16T (-40.6%)
|
3.57T
est: 3.90T (-8.4%)
|
3.72T
3.72T – 3.72T
-4.5% YoY
|
3.88T
3.88T – 3.88T
+4.2% YoY
|
| EBITDA |
220.28B
est: 437.89B (-49.7%)
|
-18.37B
est: 717.81B (-102.6%)
|
264.16B
est: 641.35B (-58.8%)
|
83.32B
est: 551.88B (-84.9%)
|
199.88B
est: 462.55B (-56.8%)
|
201.73B
est: 591.89B (-65.9%)
|
386.22B
est: 605.93B (-36.3%)
|
73.46B
est: 706.60B (-89.6%)
|
464.71B
est: 493.42B (-5.8%)
|
530.64B
est: 467.18B (+13.6%)
|
175.43B
est: 438.09B (-60.0%)
|
418.18B
418.18B – 418.18B
-4.5% YoY
|
435.66B
435.66B – 435.66B
+4.2% YoY
|
| EBIT |
206.17B
est: 405.23B (-49.1%)
|
-31.86B
est: 664.26B (-104.8%)
|
252.19B
est: 593.51B (-57.5%)
|
72.45B
est: 510.71B (-85.8%)
|
177.51B
est: 428.04B (-58.5%)
|
179.86B
est: 547.74B (-67.2%)
|
364.51B
est: 560.73B (-35.0%)
|
50.64B
est: 653.89B (-92.3%)
|
441.69B
est: 456.61B (-3.3%)
|
503.30B
est: 436.34B (+15.3%)
|
175.43B
est: 409.18B (-57.1%)
|
390.58B
390.58B – 390.58B
-4.5% YoY
|
406.91B
406.91B – 406.91B
+4.2% YoY
|
| Net Income |
157.90B
est: 244.78B (-35.5%)
|
12.00B
est: 250.56B (-95.2%)
|
190.01B
est: 195.21B (-2.7%)
|
50.41B
est: 63.52B (-20.6%)
|
115.23B
est: 117.01B (-1.5%)
|
120.06B
est: 109.70B (+9.4%)
|
275.62B
est: 235.00B (+17.3%)
|
-11.36B
est: 142.74B (-108.0%)
|
239.83B
est: 245.14B (-2.2%)
|
314.29B
est: 316.81B (-0.8%)
|
124.49B
est: 153.86B (-19.1%)
|
223.64B
223.64B – 223.64B
+45.4% YoY
|
240.91B
240.91B – 240.91B
+7.7% YoY
|
| SGA |
155.02B
est: 131.32B (+18.1%)
|
147.38B
est: 215.26B (-31.5%)
|
168.09B
est: 192.33B (-12.6%)
|
154.83B
est: 165.50B (-6.4%)
|
156.94B
est: 138.71B (+13.1%)
|
152.73B
est: 177.50B (-14.0%)
|
154.93B
est: 181.71B (-14.7%)
|
71.72B
est: 211.90B (-66.2%)
|
90.06B
est: 147.97B (-39.1%)
|
82.11B
est: 114.74B (-28.4%)
|
—
est: 107.60B (-100.0%)
|
102.71B
102.71B – 102.71B
-4.5% YoY
|
107.00B
107.00B – 107.00B
+4.2% YoY
|
| EPS |
1,547.00
est: 1,569.68 (-1.4%)
|
118.00
est: 1,606.80 (-92.7%)
|
1,327.00
est: 1,251.86 (+6.0%)
|
351.38
est: 407.33 (-13.7%)
|
720.26
est: 750.36 (-4.0%)
|
770.31
est: 703.50 (+9.5%)
|
1,768.39
est: 1,507.00 (+17.3%)
|
475.07
est: 915.33 (-48.1%)
|
1,736.18
est: 1,572.00 (+10.4%)
|
2,014.08
est: 1,963.40 (+2.6%)
|
771.53
est: 953.50 (-19.1%)
|
1,386.00
1,386.00 – 1,386.00
+45.4% YoY
|
1,493.00
1,493.00 – 1,493.00
+7.7% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-13 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-12 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-11 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-08 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-07 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-06 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-04 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-30 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-29 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-28 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-27 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-24 | B+ | 3/5 | 4/5 | 3/5 | 3/5 | 2/5 | 3/5 | 3/5 |
| 2026-04-23 | B+ | 3/5 | 4/5 | 3/5 | 3/5 | 2/5 | 3/5 | 3/5 |
| 2026-04-22 | B+ | 3/5 | 4/5 | 3/5 | 3/5 | 2/5 | 3/5 | 3/5 |
| 2026-04-21 | B+ | 3/5 | 4/5 | 3/5 | 4/5 | 2/5 | 3/5 | 3/5 |
| 2026-04-20 | B+ | 3/5 | 4/5 | 3/5 | 4/5 | 2/5 | 3/5 | 3/5 |
| 2026-04-17 | B+ | 3/5 | 4/5 | 3/5 | 4/5 | 2/5 | 3/5 | 3/5 |
| 2026-04-16 | B+ | 3/5 | 4/5 | 3/5 | 4/5 | 2/5 | 3/5 | 3/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Samsung KODEX Insurance ETF 140700.KS | 1.40% | 469.5K | 0.45% |
| 2 | Kodex KOSPI 226490.KS | 0.03% | 212.5K | 0.15% |
| 3 | FlexShares Morningstar Emerging Markets Factor Tilt Index Fund TLTE | 0.02% | 72.2K | 0.58% |
| 4 | Kodex MSCI Quality 275300.KS | 0.02% | 7.3K | 0.30% |
| 5 | Avantis Emerging Markets Value ETF AVES | 0.02% | 263.1K | 0.36% |
| 6 | iShares MSCI AC Far East ex-Japan Small Cap UCITS ETF ISFE.L | 0.01% | 10.8K | 0.74% |
| 7 | Avantis Emerging Markets Small Cap Equity ETF AVEE | 0.01% | 14.8K | 0.42% |
| 8 | iShares MSCI EM Small Cap UCITS ETF IEMS.L | 0.01% | 33.3K | 0.74% |
| 9 | State Street SPDR MSCI Emerging Markets Small Cap UCITS ETF EMSD.L | 0.01% | 52.8K | 0.55% |
| 10 | Schwab International Small-Cap Equity ETF SCHC | 0.01% | 405.2K | 0.06% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Hyun Jeon Kim | Vice President & Chief Information Officer | 816M | male |
| Xuefeng Jin | Chief Financial Officer, MD, Head of Management Division, Executive Vice President & Director | 765M | male |
| Soo-Bong Kim | Vice President & CCO | 657M | male |
| JunHee Lee | Head of Digital, CISO, CPO, Credit Information & Administration | — | male |
| Dai Gou Sung | Chief Executive Officer & Inside Director | — | — |
| Kyeongwon Kim | Head of Product | — | male |
| Songxian Tan | Director of Corporate Finance | — | male |
| Kwang-Soo Lee | Director & DM Head Officer | — | male |
| Jeong-hoon Lee | Communications Officer | — | male |
| Jinhee Won | Director & Chief Operating Officer | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 082640.KS
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
